Unloading in Heart Failure Cardiogenic Shock
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 456 participants.
Also called NCT05064202
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 456 participants
- Registry
-
NCT05064202
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT05064202. Randomized; no masking; primary purpose treatment. Start 2023-10-01 (anticipated); primary completion 2027-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Unloading in Heart Failure Cardiogenic Shock
- Acronym
- UNLOAD HF-CS
- Condition
- Cardiogenic Shock
- Intervention (Device)
- Impella 5.5
- Intervention (Drug)
- Inotropes
- Lead sponsor
- Amsterdam UMC, location VUmc
- Collaborator
- Abiomed Inc.
Record details
- Record id
cardio:ct-nct05064202- Content hash
49d41bebf096723d26292c4742626d9c31a678835022ba2dded99f6ffb9bddc3